References
Casini, A., Alberio, L., Angelillo-Scherrer, A., Fontana, P., Gerber,
B., Graf, L., . . . Asmis, L. (2020). Thromboprophylaxis and laboratory
monitoring for in-hospital patients with COVID-19 - a Swiss consensus
statement by the Working Party Hemostasis. Swiss Med Wkly, 150 ,
w20247. doi:10.4414/smw.2020.20247
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., . . . Ning, Q.
(2020). Clinical and immunological features of severe and moderate
coronavirus disease 2019. J Clin Invest, 130 (5), 2620-2629.
doi:10.1172/jci137244
Chen, Q., Zheng, Z., Zhang, C., Zhang, X., Wu, H., Wang, J., . . .
Zheng, C. (2020). Clinical characteristics of 145 patients with corona
virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China.Infection . doi:10.1007/s15010-020-01432-5
Connors, J. M., & Levy, J. H. (2020). COVID-19 and its implications for
thrombosis and anticoagulation. Blood .
doi:10.1182/blood.2020006000
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020). Prevalence of
venous thromboembolism in patients with severe novel coronavirus
pneumonia. J Thromb Haemost . doi:10.1111/jth.14830
Diagnosis and Treatment of Pneumonia Caused by SARS-CoV-2(version
7).National Health Commission of the People’s Republic of China.
Retrieved fromhttp://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf
Du, R. H., Liang, L. R., Yang, C. Q., Wang, W., Cao, T. Z., Li, M., . .
. Shi, H. Z. (2020). Predictors of Mortality for Patients with COVID-19
Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study. Eur
Respir J . doi:10.1183/13993003.00524-2020
Escher, R., Breakey, N., & Lammle, B. (2020). Severe COVID-19 infection
associated with endothelial activation. Thromb Res, 190 , 62.
doi:10.1016/j.thromres.2020.04.014
Fogarty, H., Townsend, L., Ni Cheallaigh, C., Bergin, C.,
Martin-Loeches, I., Browne, P., . . . JS, O. D. (2020). COVID-19
Coagulopathy in Caucasian patients. Br J Haematol .
doi:10.1111/bjh.16749
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., . .
. China Medical Treatment Expert Group for, C. (2020). Clinical
Characteristics of Coronavirus Disease 2019 in China. The New
England journal of medicine . Retrieved from <Go to
ISI>://MEDLINE:32109013. doi:10.1056/NEJMoa2002032
Huang, C., Wang, Y., & Li, X. (2020). Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China (vol 395, pg 497,
2020). Lancet, 395 (10223), 496-496. Retrieved from <Go
to ISI>://WOS:000514576900031.
doi:10.1016/s0140-6736(20)30252-x
Ji, D., Zhang, D., Xu, J., Chen, Z., Yang, T., Zhao, P., . . . Qin, E.
(2020). Prediction for Progression Risk in Patients with COVID-19
Pneumonia: the CALL Score. Clin Infect Dis .
doi:10.1093/cid/ciaa414
Kline, J. A., Garrett, J. S., Sarmiento, E. J., Strachan, C. C., &
Courtney, D. M. (2020). Over-Testing for Suspected Pulmonary Embolism in
American Emergency Departments: The Continuing Epidemic. Circ
Cardiovasc Qual Outcomes, 13 (1), e005753.
doi:10.1161/circoutcomes.119.005753
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., . . .
Sung, J. J. (2003). A major outbreak of severe acute respiratory
syndrome in Hong Kong. N Engl J Med, 348 (20), 1986-1994.
doi:10.1056/NEJMoa030685
Liao, S., Woulfe, T., Hyder, S., Merriman, E., Simpson, D., & Chunilal,
S. (2014). Incidence of venous thromboembolism in different ethnic
groups: a regional direct comparison study. J Thromb Haemost,
12 (2), 214-219. doi:10.1111/jth.12464
Liu, M., He, P., Liu, H. G., Wang, X. J., Li, F. J., Chen, S., . . . Li,
C. H. (2020). [Clinical characteristics of 30 medical workers infected
with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za
Zhi, 43 (3), 209-214. doi:10.3760/cma.j.issn.1001-0939.2020.03.014
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., . . . Luo, H. B.
(2020). Potential therapeutic effects of dipyridamole in the severely
ill patients with COVID-19. Acta Pharm Sin B .
doi:10.1016/j.apsb.2020.04.008
Liu, Y., Liao, W., Wan, L., Xiang, T., & Zhang, W. (2020). Correlation
Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count
Disease Severity in Patients with COVID-19. Viral Immunol .
doi:10.1089/vim.2020.0062
Luo, D., Wan, X., Liu, J., & Tong, T. (2018). Optimally estimating the
sample mean from the sample size, median, mid-range, and/or mid-quartile
range. Stat Methods Med Res, 27 (6), 1785-1805.
doi:10.1177/0962280216669183
Mattiuzzi, C., & Lippi, G. (2020). Which lessons shall we learn from
the 2019 novel coronavirus outbreak? Ann Transl Med, 8 (3), 48.
doi:10.21037/atm.2020.02.06
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., &
Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and
immunosuppression. Lancet, 395 (10229), 1033-1034.
doi:10.1016/s0140-6736(20)30628-0
Schwameis, M., Steiner, M. M., Schoergenhofer, C., Lagler, H., Buchtele,
N., Jilma-Stohlawetz, P., . . . Jilma, B. (2015). D-dimer and histamine
in early stage bacteremia: A prospective controlled cohort study.Eur J Intern Med, 26 (10), 782-786. doi:10.1016/j.ejim.2015.10.024
Shorr, A. F., Trotta, R. F., Alkins, S. A., Hanzel, G. S., & Diehl, L.
F. (1999). D-dimer assay predicts mortality in critically ill patients
without disseminated intravascular coagulation or venous thromboembolic
disease. Intensive Care Med, 25 (2), 207-210.
doi:10.1007/s001340050817
Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation
parameters are associated with poor prognosis in patients with novel
coronavirus pneumonia. J Thromb Haemost . doi:10.1111/jth.14768
Turak, O., Canpolat, U., Özcan, F., Yayla, Ç., Mendi, M. A., Öksüz, F.,
. . . Gölbaşı, Z. (2014). D-dimer level predicts in-hospital mortality
in patients with infective endocarditis: A prospective single-centre
study. Thromb Res, 134 (3), 587-592.
doi:10.1016/j.thromres.2014.06.015
Wan, X., Wang, W., Liu, J., & Tong, T. (2014). Estimating the sample
mean and standard deviation from the sample size, median, range and/or
interquartile range. BMC Med Res Methodol, 14 , 135.
doi:10.1186/1471-2288-14-135
Wei, Y. Y., Wang, R. R., Zhang, D. W., Tu, Y. H., Chen, C. S., Ji, S., .
. . Fei, G. H. (2020). Risk factors for severe COVID-19: Evidence from
167 hospitalized patients in Anhui, China. J Infect .
doi:10.1016/j.jinf.2020.04.010
Wenzel, C., Kofler, J., Locker, G. J., Laczika, K., Quehenberger, P.,
Frass, M., & Knobl, P. (2002). Endothelial cell activation and blood
coagulation in critically ill patients with lung injury. Wien Klin
Wochenschr, 114 (19-20), 853-858.
White, R. H., & Keenan, C. R. (2009). Effects of race and ethnicity on
the incidence of venous thromboembolism. Thromb Res, 123 Suppl 4 ,
S11-17. doi:10.1016/s0049-3848(09)70136-7
World Health Organization. Coronavirus disease 2019 (COVID-19)
Situation Report–149. June 17,2020. Retrieved fromhttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200617-covid-19-sitrep-149.pdf?sfvrsn=3b3137b0_4
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., . . . Song, Y.
(2020). Risk Factors Associated With Acute Respiratory Distress Syndrome
and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan,
China. JAMA Intern Med . doi:10.1001/jamainternmed.2020.0994
Xie, J., Ding, C., Li, J., Wang, Y., Guo, H., Lu, Z., . . . He, H.
(2020). Characteristics of Patients with Coronavirus Disease (COVID-19)
Confirmed using an IgM-IgG Antibody Test. J Med Virol .
doi:10.1002/jmv.25930
Yan, Y., Yang, Y., Wang, F., Ren, H., Zhang, S., Shi, X., . . . Dong, K.
(2020). Clinical characteristics and outcomes of patients with severe
covid-19 with diabetes. BMJ Open Diabetes Res Care, 8 (1).
doi:10.1136/bmjdrc-2020-001343
Zhang, J., Liu, P., Wang, M., Wang, J., Chen, J., Yuan, W., . . . Ma, J.
(2020). The clinical data from 19 critically ill patients with
coronavirus disease 2019: a single-centered, retrospective,
observational study. Z Gesundh Wiss , 1-4.
doi:10.1007/s10389-020-01291-2
Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y.
Q., . . . Gao, Y. D. (2020). Clinical characteristics of 140 patients
infected with SARS-CoV-2 in Wuhan, China. Allergy .
doi:10.1111/all.14238
Zheng, Y., Xu, H., Yang, M., Zeng, Y., Chen, H., Liu, R., . . . Wang, D.
(2020). Epidemiological characteristics and clinical features of 32
critical and 67 noncritical cases of COVID-19 in Chengdu. J Clin
Virol, 127 , 104366. doi:10.1016/j.jcv.2020.104366
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., . . . Cao, B.
(2020). Clinical course and risk factors for mortality of adult
inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet, 395 (10229), 1054-1062. doi:10.1016/s0140-6736(20)30566-3
Zhu, Z., Cai, T., Fan, L., Lou, K., Hua, X., Huang, Z., & Gao, G.
(2020). Clinical value of immune-inflammatory parameters to assess the
severity of coronavirus disease 2019. Int J Infect Dis .
doi:10.1016/j.ijid.2020.04.041
Zou, Y., Guo, H., Zhang, Y., Zhang, Z., Liu, Y., Wang, J., . . . Qian,
Z. (2020). Analysis of coagulation parameters in patients with COVID-19
in Shanghai, China. Biosci Trends . doi:10.5582/bst.2020.03086